Skip to content
CIVIC HERALD
HR 3789 · 119th Congress · HouseIn committee

DTC Act of 2025

In plain language: Drug-price Transparency for Consumers Act of 2025 or the DTC Act of 2025 This bill requires consumer advertisements for prescription drugs and biological products to include certain price information if the drug or biologic is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law. Specifically, such advertisements must clearly and conspicuously disclose the wholesale price for a 30-day supply of the drug or biologic and may explain that a consumer may pay a different amount for the drug or biologic depending on the consumer's health insurance coverage. The requirement does not apply to advertisements for drugs or biologics with a wholesale cost of less than $35 for a one-month supply. Each violation of this requirement is subject to a civil penalty of not more than $100,000.

Provisional: our plain-language summary, pending review.

Provisionalunreviewed: summary
People affectednot yet estimated
Fiscal magnitudenot yet estimated
Reach
Your matchSign in →See how this matches your values.

How your members of Congress line up

Loading your members of Congress…

Timeline

How it moved.

  1. Jun 5, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  2. Jun 5, 2025Introduced in House
  3. Jun 5, 2025Introduced in House

Sources & provenance

Congress.govrefreshed 23 days ago

Checking your session…